Bayer says it is cutting about 4,500 jobs worldwide and creating 2,500 “particularly in the emerging markets” as it focuses “on researching, developing and marketing new products, particularly in HealthCare and CropScience.”

The company’s statement did not specify which divisions would see losses or gains. It did say that approximately 1,700 jobs would go from the company’s home country, Germany.

Bayer CropScience’s headquarters for its Americas operation is in RTP. The global headquarters for the division is in Monheim, Germany.

“To finance the expansion of our growth activities, we … need to redirect resources, improve efficiencies and cut costs,” said Bayer AG Management Board Chairman Dr. Marijn Dekkers.

“Bayer has great business potential in all three subgroups. To better exploit this potential, we must continue to bundle existing resources and streamline our structures. That is the only way we can sustainably finance our investment in growth and innovation – for example in new pharmaceutical products, in our BioScience business and in the expansion of our capacities in Asia,” Dekkers said in the statement.

Get the latest news alerts: Follow LTW at Twitter.